Congress Demands Answers on Data Privacy Ahead of 23andMe Sale

As news broke of the impending sale of genetic testing company 23andMe, members of Congress have started demanding answers regarding data privacy concerns.

The company, known for its at-home DNA testing kits, has faced criticism in the past for its handling of customer data and potential data privacy breaches.

With the sale of 23andMe on the horizon, lawmakers are seeking assurances that customer data will be protected and used responsibly by the new owners.

Concerns have been raised over the potential for sensitive genetic information to be mishandled or exploited by third parties.

Congress is calling for transparency from both 23andMe and the prospective buyers regarding their data privacy practices and policies.

Lawmakers are also considering new regulations to ensure that genetic data is adequately protected from misuse and abuse.

The sale of 23andMe has underscored the need for stronger data privacy laws and regulations to safeguard consumer information in an increasingly digital world.

Many are calling for greater oversight and accountability in the handling of genetic information, which is uniquely personal and sensitive.

As Congress continues to push for answers on data privacy issues, the future of genetic testing and data protection remains uncertain.

Stay tuned for updates on this developing story as lawmakers work to address concerns and protect consumer privacy in the era of widespread genetic testing.